![]() |
|
|
H Ouadid, J Seguin, A Dumuis, J Bockaert and J Nargeot
CRBM, CNRS UPR 8402/INSERM U 249, Montpellier, France.
In various species, including humans, 5-hydroxytryptamine (5-HT) has been shown to exert positive chronotropic and inotropic cardiac effects through different types of receptors. The goal of the present study was to investigate the regulation by 5-HT of voltage-gated Ca2+ channels in human atrial myocytes and to characterize the receptor involved. Cardiomyocytes isolated enzymatically and mechanically were voltage- clamped using the whole-cell configuration of the patch-clamp technique. Extracellular perfusion of 5-HT increased Ca2+ current (ICa) amplitude with a EC50 (0.1 microM) similar to that observed with isoprenaline. The effects of 5-HT were blocked by the addition of protein kinase A inhibitor in the pipette. In addition, the effects of 5-HT, isoprenaline, and intracellular cAMP on ICa were not additive. These results support the hypothesis that the inotropic effect of 5-HT in human atrial myocytes is related to an increase of ICa via an elevation of intracellular cAMP levels and stimulation of cAMP- dependent protein kinase. The effects of 5-HT were not blocked by antagonists of 5-HT1 (methiothepin), 5-HT2 (ketanserin), or 5-HT3 (ICS 205-930 at a low concentration) receptors. The benzamide derivatives renzapride and zacopride and the azabicyclobenzimidazolone derivative BIMU 8 increased ICa, but less efficiently than did 5-HT or 5- methoxytryptamine. Moreover, ICS 205-930 at high concentrations (greater than 1 microM) completely antagonized the effects of 5-HT. Thus, the pharmacology of the 5-HT receptor involved in an increase of ICa in human atrial myocytes resembles that recently described for the 5-HT4 receptor. In atrial myocytes dissociated from rat, rabbit, guinea pig, or frog, 5-HT at high concentrations had no effect on Ca2+ currents, suggesting that the distribution of 5-HT4 receptors in cardiac tissues is species dependent.
This article has been cited by other articles:
![]() |
J. A. K. Birkeland, F. Swift, N. Tovsrud, U. Enger, P. K. Lunde, E. Qvigstad, F. O. Levy, O. M. Sejersted, and I. Sjaastad Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2367 - H2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu, M. S. Geddis, Y. Wen, W. Setlik, and M. D. Gershon Expression and function of 5-HT4 receptors in the mouse enteric nervous system Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1148 - G1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Qu, G. Baroudi, Y. Yue, N. El-Sherif, and M. Boutjdir Localization and modulation of {alpha}1D (Cav1.3) L-type Ca channel by protein kinase A Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2123 - H2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pau, A. J. Workman, K. A. Kane, and A. C. Rankin Electrophysiological Effects of Prucalopride, a Novel Enterokinetic Agent, on Isolated Atrial Myocytes from Patients Treated with {beta}-Adrenoceptor Antagonists J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 146 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cao, J. H. Han, S. Z. Kim, K. W. Cho, and S. H. Kim Diverse regulation of atrial natriuretic peptide secretion by serotonin receptor subtypes Cardiovasc Res, August 1, 2003; 59(2): 360 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yusuf and A. J. Camm Sinus Tachyarrhythmias and the Specific Bradycardic Agents: A Marriage Made in Heaven? Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 89 - 105. [Abstract] [PDF] |
||||
![]() |
A. Pindon, G. van Hecke, P. van Gompel, A. S. Lesage, J. E. Leysen, and M. Jurzak Differences in Signal Transduction of Two 5-HT4 Receptor Splice Variants: Compound Specificity and Dual Coupling with Galpha s- and Galpha i/o-Proteins Mol. Pharmacol., January 1, 2002; 61(1): 85 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boixel, S. Dinanian, L. Lang-Lazdunski, J.-J. Mercadier, and S. N. Hatem Characterization of effects of endothelin-1 on the L-type Ca2+ current in human atrial myocytes Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H764 - H773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barrere-Lemaire, C. Piot, F. Leclercq, J. Nargeot, and S. Richard Facilitation of L-type calcium currents by diastolic depolarization in cardiac cells: impairment in heart failure Cardiovasc Res, August 1, 2000; 47(2): 336 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boixel, S. Tessier, Y. Pansard, L. Lang-Lazdunski, J.-J. Mercadier, and S. N. Hatem Tyrosine kinase and protein kinase C regulate L-type Ca2+ current cooperatively in human atrial myocytes Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H670 - H676. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Rahme, B. Cotter, E. Leistad, M. K. Wadhwa, R. Mohabir, A. P. D. W. Ford, R. M. Eglen, and G. K. Feld Electrophysiological and Antiarrhythmic Effects of the Atrial Selective 5-HT4 Receptor Antagonist RS-100302 in Experimental Atrial Flutter and Fibrillation Circulation, November 9, 1999; 100(19): 2010 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pino, E. Cerbai, G. Calamai, F. Alajmo, A. Borgioli, L. Braconi, M. Cassai, G. F. Montesi, and A. Mugelli Effect of 5-HT4 receptor stimulation on the pacemaker current If in human isolated atrial myocytes Cardiovasc Res, December 1, 1998; 40(3): 516 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sanders, J. A. Lynham, B. Bond, F. del Monte, S. E. Harding, and A. J. Kaumann Sensitization of Human Atrial 5-HT4 Receptors by Chronic ß-Blocker Treatment Circulation, November 1, 1995; 92(9): 2526 - 2539. [Abstract] [Full Text] |
||||
![]() |
C. Boixel, W. Gonzalez, L. Louedec, and S. N. Hatem Mechanisms of L-Type Ca2+ Current Downregulation in Rat Atrial Myocytes During Heart Failure Circ. Res., September 28, 2001; 89(7): 607 - 613. [Abstract] [Full Text] [PDF] |
||||